These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 8238468

  • 1. Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs.
    Naitoh M, Suzuki H, Murakami M, Matsumoto A, Ichihara A, Nakamoto H, Yamamura Y, Saruta T.
    Am J Physiol; 1993 Oct; 265(4 Pt 2):R934-42. PubMed ID: 8238468
    [Abstract] [Full Text] [Related]

  • 2. Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
    Naitoh M, Suzuki H, Murakami M, Matsumoto A, Arakawa K, Ichihara A, Nakamoto H, Oka K, Yamamura Y, Saruta T.
    Am J Physiol; 1994 Dec; 267(6 Pt 2):H2245-54. PubMed ID: 7810724
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide may participate in V2 vasopressin-receptor-mediated renal vasodilation.
    Aki Y, Tamaki T, Kiyomoto H, He H, Yoshida H, Iwao H, Abe Y.
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):331-6. PubMed ID: 7511766
    [Abstract] [Full Text] [Related]

  • 4. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
    Furukawa Y, Takayama S, Ren LM, Sawaki S, Inoue Y, Chiba S.
    J Pharmacol Exp Ther; 1992 Nov; 263(2):627-31. PubMed ID: 1331408
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of receptor blockade on metabolism and renal actions of vasopressin in conscious dogs.
    Grove L, Christensen P, Bie P.
    Acta Physiol Scand; 1998 May; 163(1):93-101. PubMed ID: 9648627
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
    Bernat A, Hoffmann P, Dumas A, Serradeil-le Gal C, Raufaste D, Herbert JM.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vascular effects alter early-gestation fetal renal responses to vasopressin.
    Ervin MG, Terry KA, Calvario GC, Castro R, Ross MG, Leake RD, Fisher DA.
    Am J Physiol; 1994 Mar; 266(3 Pt 2):R722-9. PubMed ID: 8160865
    [Abstract] [Full Text] [Related]

  • 12. Renal versus hindquarter hemodynamic responses to vasopressin in conscious rats.
    Harrison-Bernard LM, Brizzee BL, Clifton GG, Walker BR.
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):719-26. PubMed ID: 1703592
    [Abstract] [Full Text] [Related]

  • 13. In vivo diuretic actions of renal vasopressin V1 receptor stimulation in rats.
    Ledderhos C, Mattson DL, Skelton MM, Cowley AW.
    Am J Physiol; 1995 Mar; 268(3 Pt 2):R796-807. PubMed ID: 7900923
    [Abstract] [Full Text] [Related]

  • 14. Effect of vasopressin V (OPC-21268) and V2 (OPC-31260) antagonists on renal hemodynamics and excretory function.
    Nakamura T, Sakamaki T, Kurashina T, Hoshino J, Sato K, Ono Z, Murata K.
    Life Sci; 1994 Mar; 55(4):PL67-72. PubMed ID: 8028441
    [Abstract] [Full Text] [Related]

  • 15. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF.
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [Abstract] [Full Text] [Related]

  • 16. cAMP and extrarenal vasopressin V2 receptors in dogs.
    Liard JF.
    Am J Physiol; 1992 Dec; 263(6 Pt 2):H1888-91. PubMed ID: 1336316
    [Abstract] [Full Text] [Related]

  • 17. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs.
    Liard JF.
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H99-106. PubMed ID: 8304528
    [Abstract] [Full Text] [Related]

  • 18. V2 receptor-mediated vasodilation in healthy humans.
    Tagawa T, Imaizumi T, Shiramoto M, Endo T, Hironaga K, Takeshita A.
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):387-92. PubMed ID: 7769802
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of vasopressin natriuresis in the dog: role of vasopressin receptors and prostaglandins.
    Kompanowska-Jezierska E, Emmeluth C, Grove L, Christensen P, Sadowski J, Bie P.
    Am J Physiol; 1998 Jun; 274(6):R1619-25. PubMed ID: 9608016
    [Abstract] [Full Text] [Related]

  • 20. Effects of V1- and V2-vasopressin (AVP) antagonists on the pressor, AVP and atrial natriuretic peptide responses to a hypertonic saline infusion in conscious anephric rats.
    Ota K, Kimura T, Inoue M, Funyu T, Shoji M, Sato K, Ohta M, Yamamoto T, Abe K.
    Eur J Endocrinol; 1995 Jul; 133(1):127-32. PubMed ID: 7627334
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.